2219
vs
H
Hang Seng (Hong Kong)
2219
Over the past 12 months, Chaoju Eye Care Holdings Ltd has underperformed Hang Seng (Hong Kong), delivering a return of -6% compared to the Hang Seng (Hong Kong)'s +28% growth.
Stocks Performance
2219 vs Hang Seng (Hong Kong)
Performance Gap
2219 vs Hang Seng (Hong Kong)
Performance By Year
2219 vs Hang Seng (Hong Kong)
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Chaoju Eye Care Holdings Ltd
Glance View
Chaoju Eye Care Holdings Ltd. engages in the provision of ophthalmic medical services. The company is headquartered in Beijing, Beijing. The company went IPO on 2021-07-07. The firm operates its businesses through two segments. The Consumer Ophthalmic Services segment provides refractive correction (including presbyopia correction), myopia control and provides optical products and services. The Basic Ophthalmic Services segment provides treatments of a wide range of common eye diseases, including cataract, glaucoma, squint, ocular fundus diseases, ocular surface diseases, orbital diseases and pediatric eye diseases, which may be covered by public health insurance programs. The firm mainly conducts its businesses in the domestic market.